Covid Vaccine

COVID BREAKING: Vaccination drive for 18+ age opens from May 1,2021

COVID BREAKING: Vaccination drive for 18+ age opens from May 1,2021

In a significant development, the Government of India on Monday decided to give COVID19 vaccination to every one above the age of 18 years from May 1. The Government of India announced a "Liberalised and Accelerated" Phase 3 Strategy of Covid-19 Vaccination from 1st May. In a meeting chaired by PM Narendra Modi, an important decision of allowing vaccination to everyone above the age of 18 from 1st May has been taken, said a press release issued by the Ministry of Health and Family Welfare.  Phase-I of…
Read More
Deputy C.M Ajit Pawar warns full lockdown if people don’t follow restrictions.

Deputy C.M Ajit Pawar warns full lockdown if people don’t follow restrictions.

Amid an alarming rise in Coronavirus caseload in Maharashtra, deputy Chief Minister Ajit Pawar on Friday warned that if people don't follow COVID-19 restrictions then the government will be forced to impose a lockdown in the state as stringent as the last year's. "If people don't adhere to the currently imposed COVID restrictions then we may have to impose lockdown like last year," Ajit Pawar said. Also Read - Maharashtra Comes Under Curfew-Like Curbs, Over 2 Lakh Cops Deployed To Enforce Restrictions. Further, Pawar insisted doctors to…
Read More
Government approved Sputnik-V vaccine in India

Government approved Sputnik-V vaccine in India

The government on Monday approved Sputnik-V, the vaccine against the coronavirus disease (Covid-19) developed by Russia. This is the third vaccine approved by India after Covishield and Covaxin. Dr Reddy's Laboratories, the Hyderabad-based pharmaceutical company, last week sought the government's approval for the vaccine to be used in India. The Russian Direct Investment Fund (RDIF) partnered with Dr Reddy's in September 2020 to conduct clinical trials of Sputnik V in India. The Russian vaccine has an efficacy of 91.6% and is conducting its Phase III clinical trials…
Read More
PM Modi flags-off largest COVID-19 vaccination drive

PM Modi flags-off largest COVID-19 vaccination drive

With Prime Minister Narendra Modi launching India's vaccination drive against the novel coronavirus and RBI Governor Shaktikanta Das saying the central bank is planning to tweak regulatory framework in order to strengthen governance in banks and NBFC's, Saturday was packed with groundbreaking news stories. Below are biggest headlines. Prime Minister Narendra Modi on Saturday virtually launched the world's largest Covid-19 immunisation programme at 10:30 am to fight the Covid-19 pandemic in India where over 1.5 lakh people have lost their lives so far. Almost three lakh beneficiaries…
Read More
INDIA’S COVID VACCINATION PLAN

INDIA’S COVID VACCINATION PLAN

PM Narendra Modi said a Covid-19 vaccine could be ready for India in a few weeks and that vaccination would begin as soon as the Centre gets a go-ahead from the scientists. During the all-party meet, Opposition parties suggested that the government must vaccinate the poor and vulnerable free of cost. The government plans to include nearly one crore health workers in the first batch of vaccine receivers, followed by nearly two crore frontline workers (police, security personnel, municipal workers, and other essential workers), and 27 crore…
Read More
Rhizen Pharma gets USFDA approval for phase one clinical trials for COVID-19 drug

Rhizen Pharma gets USFDA approval for phase one clinical trials for COVID-19 drug

New Delhi, Rhizen Pharmaceuticals, an associate company of Alembic Pharmaceuticals, on Wednesday said it has received approval from the US health regulator to commence phase one clinical trials on retroviral oral drug for the treatment of COVID-19.The Switzerland-based firm, which is a clinical-stage oncology-focussed biopharmaceutical company, has received approval for its investigational new drug (IND) application from the US Food and Drug Administration (FDA) to study its oral Dihydroorotate dehydrogenase (DHOHD) inhibitor for SARS-CoV-2 infection, Rhizen Pharmaceuticals S A said in a statement.The initial study would evaluate…
Read More
Congress MP Anand Sharma hails PM Modi’s visit to vaccine facilities but later on says to give correct statement

Congress MP Anand Sharma hails PM Modi’s visit to vaccine facilities but later on says to give correct statement

Senior Congress leader Anand Sharma on Sunday (November 29) praised Prime Minister Narendra Modi's decision to visit three vaccine facilities across the country, saying the prime minister's visit to these centres developing vaccine against coronavirus will boost the morale of frontline warriors. Sharma also said that the PM's visit will also reassure the nation about the efforts taken by the government to tackle COVID-19. Sharma's comment left everyone surprised as the Congress has mocked PM Modi's vaccine tour with Congress spokesperson Randeep Surjewala attacking the prime minister…
Read More
PM Narendra Modi reaches Ahmedabad to review COVID-19 vaccine development

PM Narendra Modi reaches Ahmedabad to review COVID-19 vaccine development

Ahmedabad: Prime Minister Narendra Modi reached Ahmedabad in Gujarat on Saturday (November 28, 2020) to review coronavirus vaccine development work. It is a part of his three-city visit to personally review the COVID-19 vaccine facilities. From the airport, PM Modi proceeded towards the Zydus Cadila's plant near Ahmedabad. The Prime Minister will talk to researchers, scientists to get information about its vaccine development. He will take stock of the progress made in the vaccine production The plant is located over 20 km from Ahmedabad in the Changodar…
Read More
Bharat Biotech starts phase III trials for Covaxin; will it be world’s cheapest vaccine?

Bharat Biotech starts phase III trials for Covaxin; will it be world’s cheapest vaccine?

Bharat Biotech on Monday announced the commencement of phase III trials of the COVID-19 vaccine, Covaxin. It is the largest clinical trial conducted for a COVID-19 vaccine in India.   The phase III trials will involve 26,000 volunteers across 25 centres in India, being conducted in partnership with ICMR. This is India’s first phase 3 efficacy study for a COVID-19 vaccine, and the largest phase III efficacy trial ever conducted in India. The trial has been registered with ICMR and approved by the Drugs Controller General of India. …
Read More
After Pfizer, Sputnik V: Russia says Covid-19 vaccine shows 92% efficacy

After Pfizer, Sputnik V: Russia says Covid-19 vaccine shows 92% efficacy

The Sputnik V vaccine candidate has demonstrated “high efficacy” in interim data, reducing by 92 per cent the possibility that those inoculated would be clinically diagnosed with symptomatic Covid-19, Russian authorities have said. The findings of the trial are not yet peer-reviewed. But they are crucial for India, where the vaccine is being tested onhumans in mid- to late-stage trials by Hyderabad-based Dr Reddy’s Laboratories. The Sputnik V announcement has come two days after American drug major Pfizer released interim information that showed its Covid-19 vaccine with…
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.